JAK2 and diffuse large B-cell lymphoma: Functional experiments showed that DCZ0858 had a tumor-suppressive effect on DLBCL cells, mainly through cell proliferation inhibition, apoptosis induction, and cell cycle arrest via the JAK2/STAT3-signaling pathway.